Formulation and Drug Delivery

Nemera Acquires Chicago Consulting Firm

August 15, 2019

Nemera has acquired a healthcare focused design and innovation consulting firm in Chicago, IL, Insight Product Development, strengthening its presence in North America.

European Commission Extends Use of Dupixent to Include Adolescents

August 15, 2019

The European Commission has approved an extension of the use of Dupixent (dupilumab) within the EU to include patients aged 12 to 17 years old with moderate-to-severe atopic dermatitis.

Amgen Wins Enbrel Patent Case, Sandoz to Appeal Ruling

August 13, 2019

A New Jersey court upheld the validity of patent claims for Amgen’s anti-inflammatory blockbuster biologic, Enbrel (etanercept).

HALIX Completes New cGMP Manufacturing Facility; Startup Slated for Q4 2019

August 12, 2019

The new facility will manufacture biopharmaceutical products under cGMP conditions.

South Korea’s Biotech Industry Projected to $23.2 Billion by 2022, According to Industry Report

August 08, 2019

South Korea’s pharma/biotech space is projected to grow to $23.2 billion by 2022, and will likely attract foreign investment, according to a new market report by GlobalData.

Colorcon, TruTag Team Up On-Dose Authentication

August 06, 2019

Under an agreement, Colorcon will incorporate TruTag’s edible microtag technology in its coatings.

Combo Drugs Require a Complex Design Approach

August 02, 2019

A design strategy can ensure conflicting properties are managed appropriately for multi-API controlled-release formulations.

Realizing the Potential of Vaccines

August 02, 2019

Pharmaceutical Technology Europe

As vaccines gain prominence within pharma, there is an expectation that specialized CDMO services will provide opportunities.

Partnering Up for Success

August 02, 2019

Pharmaceutical Technology Europe

To help customers succeed, CDMOs have moved away from the ‘fee-for-service’ model to offer flexible, full-service partnerships.

In Safe Hands

August 02, 2019

Pharmaceutical Technology Europe

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.